Edward Lain
Austin Institute for Clinical Research · Pflugerville Dermatology Clinical Research
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Edward Lain as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:42 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06376110 · Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum ProductionAustin Institute for Clinical Research · unknown · Acne · principal investigator
- Ph4NCT06090071 · Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.Austin Institute for Clinical Research · completed · Photoaging · principal investigator
- Ph4NCT05932732 · Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.Austin Institute for Clinical Research · completed · Cutis Laxa Facialis, Xeroderma · principal investigator
- N/ANCT05908825 · Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in AdultsAustin Institute for Clinical Research · completed · Photodamaged Skin · principal investigator
- Ph2NCT05713760 · Proof of Concept Study to Access Superficial Basal Cell Carcinoma in AdultsAustin Institute for Clinical Research · completed · Superficial Basal Cell Carcinoma · principal investigator
- Ph3NCT05203315 · Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in AdultsAustin Institute for Clinical Research · completed · Plaque Psoriasis · principal investigator
- Ph4NCT04940767 · A Companion Treatment Study for Patients With Moderate to Severe Acne VulgarisEdward Lain, MD · completed · Acne Vulgaris · principal investigator
- Ph2NCT04844983 · A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCCSirnaomics · completed · Squamous Cell Carcinoma in Situ · principal investigator
- Ph1NCT02424305 · Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use ConditionsLEO Pharma · completed · Actinic Keratosis · principal investigator
- Ph4NCT02249104 · A Treatment Regimen for Student Athletes With Mild to Moderate Acne VulgarisGalderma R&D · completed · Acne Vulgaris · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:42 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:42 UTC. The ranking covers the 200 most relevant of 30 PubMed records, and a shared surname and initials can bring in a namesake. All 30 on PubMed
- Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.N Engl J Med · 2021120 citationsRCR 6.4
- Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials.J Dermatolog Treat · 202242 citationsRCR 5.7
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.JAMA Dermatol · 202242 citationsRCR 3.4
- Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.J Am Acad Dermatol · 202437 citationsRCR 10.3
- Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.J Am Acad Dermatol · 202033 citationsRCR 3.6
- Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.Am J Clin Dermatol · 202233 citationsRCR 4.4
- Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.JAMA Dermatol · 202326 citationsRCR 4.1
- Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines.Aesthet Surg J · 202224 citationsRCR 3.6
- Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.J Drugs Dermatol · 201721 citationsRCR 1.8
- Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.Br J Dermatol · 202321 citationsRCR 3.3